CytoGenix, Inc. And USDA To Collaborate In Developing A synDNA(TM) Vaccine Against Costly Livestock Disease

HOUSTON--(BUSINESS WIRE)--May 8, 2006--CytoGenix, Inc. (OTCBB:CYGX - News) announced that it has entered into a formal Cooperative Research and Development Agreement (CRADA) with the USDA Agricultural Research Service. CytoGenix scientists will work with a team of USDA scientists led by Dr. Steven Olsen to develop synDNA(TM) vaccines against existing and emerging strains of the bacteria that causes brucellosis, a costly disease for ranchers and game managers. Brucellosis causes miscarriages in domestic sheep, goats, cattle, pigs, and in wildlife such as deer, elk and bison. State and Federal governments have spent $11 billion over the last 45 years in an attempt to eradicate this disease.

MORE ON THIS TOPIC